Clinical Trial Update: The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire

View source ↗

Summary

A completed AstraZeneca-sponsored study evaluating the clinical significance of minimal changes in reflux esophagitis as measured by the Gastroesophageal Reflux…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED